Won't DC Studios' 'Clayface' turn a profit on its theatrical run?

A couple of weeks ago, it hit theaters Clayfacethe DCU bet of DC Studios for horror movies.

The R-rated body horror is the studio's first production in the genre, with a plot that revolves around one of Batman's most disturbing villains.

The one directed by James Watkins (Eden Lake, Speak No Evil), with a script Mike Flanagan (The Haunting of Hill House, Doctor Sleep) y Hossein Amini (Drive), stars Tom Rhys Harries (The Gentlemen) as Matt Hagen/Clayface, the cult villain from Gotham City's gallery of enemies.

The film had a modest budget of $44 million, plus marketing costs, and while early signs following its theatrical release seemed promising, Clayface has not been able to take flight during its run in cinemas.

IT IS REPORTED THAT CLAYFACE IT WILL NOT RECOVER YOUR BUDGET OR GENERATE PROFITS DURING ITS TIME IN CINEMA; IS THE INFORMATION ACCURATE?

Clayface It premiered at the end of October in 3,458 theaters in the United States, and in first place at the box office, grossing $24 million dollars (USA, Canada), while at the international box office (79 markets) it added $19 million dollars, for a total global premiere of $43 million dollars.

A new report from Variety reports that the body horror will not break even—that is, it will not recover its budget—until the studio takes into account the income generated in stages after its theatrical release, despite have raised to date, $109 million dollars against a budget of $44 million.

Curiously, the information is made public within the framework of media coverage regarding the departure of James Gunn and Peter Safran from DC Studios.

This contradicts previous information. Several media outlets had indicated that the film had already surpassed the profitability threshold after reaching $100 million worldwide just two weeks after its release.

But before believing that this is a conspiracy against DC, let's clarify: The discrepancy lies in the calculations: The reported production budget does not include marketing expenses, and theaters keep a cut of each ticket sold.

A general rule suggests that, to reach the break-even point, a film must gross approximately 2.5 times its production budgetwhich would place the goal for this film at around $110 million dollars. Under this premise, The stock is, right now, just below said figure and with real possibilities of registering profits.

Other analysts maintain that the actual theatrical revenue target could be considerably higher, depending on how much the studio has invested in its promotion.

To this we must also add the fact that Clayface lost more than 530 theaters entering its third weekend, while Godzilla Minus Zero took first place, in a clear indication that DC Studios' body horror has probably already reached its ceiling.

Clayface It's not a disaster. A film can still recoup its investment through streaming, the home market, television broadcast rights and licensing deals; and, according to the media, that seems to be the path it will follow. It is far from being a major failure, although it is not the resounding box office victory that some fans, or the studio itself, expected.

Inspired by the DC Comics character, The plot revolves around the mutilation of Matt Hagen. The promising Gotham City actor sleeps with the girlfriend of a local mafia boss, who, in retaliation, disfigures his face. Desperate for a solution, he contacts scientist Dr. Caitlyn Corr (Naomi Ackie, Blink Twice), who injects him with a serum with monstrous side effects.

The solution allows you to reshape your face and its shape, becoming a walking piece of clay. He is based on the supervillain who debuted in 1940's Detective Comics #440.

The plot is set prior to the events of Superman (2025).